Oncology research: The right model for the right purpose

Join us as we discuss:

• Selecting the most appropriate model and levels of immunodeficiency
• Modelling a human immune system and T cell-based therapy with triple-immunodeficient mice
• Tracking tumour progression via checkpoint inhibitors in syngeneic mice
• Navigating the cancer model database to support your in vivo and in vitro studies

Speaker

Julia Schueler, DVM, PhD

Research Director, Charles River